2018 Healthcare Safety Specialization 
PM360
SEPTEMBER 15, 2022
In many of the states where abortion is banned, strictly regulated, or soon to be restricted, the procedure is legal only in instances of a life-threatening situation, but no regulations define what such a situation may be, leaving 70% of physicians unclear about when to intervene for maternal safety. Qualio surveyed 2,002 U.S.
European Pharmaceutical Review
FEBRUARY 21, 2023
After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? He founded Celadon in 2018.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
MARCH 22, 2024
“For many years, our expertise in vision technology has been key in developing automotive solutions that improve driver safety,” said Neil Boehm, Chief Technology Officer at Gentex. Patient advocacy has never been more important, especially as the rapid proliferation of Gen AI sweeps through the healthcare space.
Pharma Marketing Network
OCTOBER 26, 2020
For companies that process “special categorizes of data, through research and clinical trials etc.,” The GDPR requires any company that processes large amounts of special categories of personal data to appoint a data protection officer , either by recruitment of a new employee or via an outsourced data protection officer.
Clarivate
MAY 11, 2023
Over the past five years, healthcare leaders in Mainland China have made significant strides in their efforts to reduce lag time in availability of novel drugs versus western markets. In parallel, the CDE also established a special channel to facilitate these approvals.
Clarivate
MAY 24, 2022
6] [7] However, in May 2018, the National Health Commission of China (NHC), together with four other national agencies, formulated China’s First List of Rare Diseases (CRDL) to provide a foundation for policymaking around rare disease treatments. 10] [11] [12]. 10] [11] [12]. Source: Mainland China’s Center for Drug Evaluation.
PM360
APRIL 7, 2023
It’s never too early in the research and development (R&D) process to identify and measure a product’s projected clinical outcomes in order to meet the needs and expectations of payers and healthcare professionals (HCPs) who are the final arbiters of a product’s commercial success.
Expert insights. Personalized for you.
52 
Let's personalize your content